Apr 13, 2020
Toxic Cell Atlas Guides New Therapies for Neurodegeneration
Apr 07, 2020
PTC Announces Regulatory Update on Risdiplam for Spinal Muscular Atrophy (SMA)
Mar 12, 2020
Metachromatic Leukodystrophy (MLD) Market Assessment, 2020 - Pipeline Products, Unmet Needs, Market Drivers & Barriers, Competitive Landscape
Mar 05, 2020
Amyloidosis Patient Registry Hits 300 Participants and is Now Available to Entire Community
Feb 13, 2020
RegeneRx Partner Receives Canadian Patent For Treatment of Peripheral Neuropathy
Feb 12, 2020
Global Bell's Palsy Incidence Assessment by Ethnicity & Geography, 2019-2029
Feb 12, 2020
Houston Museum of Natural Science Is Now A Certified Autism Center(TM)
Feb 10, 2020
Global DEE Market Insights, 2017-2028 - Eisai Pharmaceuticals (Fycompa; Perampanel), Zogenix (Fintepla; ZX008), Takeda/Ovid (Soticlestat; TAK-935/OV935), and Zynerba Pharma (Zygel; ZYN002)
Feb 06, 2020
Newport Beach Institute Launches Home-Based Vestibular Virtual Reality System Used to Treat Mark Cuban for Dizziness
Feb 06, 2020
NeuroSense Therapeutics Receives Orphan Drug Designation for Amyotrophic Lateral Sclerosis (ALS) Drug, and Announces Initiation of Two Clinical Studies in ALS
Feb 06, 2020
Cellectricon and StressMarq Biosciences collaborate to develop next generation reagents and assays to advance neurodegenerative disease research
Feb 06, 2020
AFTD Welcomes Rosa Canet-Avilés, Ph.D., as Senior Director of Scientific Initiatives
Feb 06, 2020
SUNFISH Pivotal Results for Risdiplam (RG7916) Demonstrate Medically Meaningful Benefit in Broadest Age Group of Patients Studied with Type 2 and 3 Spinal Muscular Atrophy
Feb 04, 2020
CytRx Corporation Highlights Updated Arimoclomol Milestone Guidance Provided by Licensee Orphazyme A/S
Feb 03, 2020
Researchers use Virtual Reality to Teach Street-Crossing Skills to Children with Autism
Feb 03, 2020
PTC Therapeutics to Host A Conference Call to Review Part 2 of the SUNFISH Clinical Trial Data at the SMA Europe Conference
Jan 30, 2020
VistaGen Therapeutics Receives FDA Clearance of IND for Phase 2 Clinical Study of AV-101 as a Potential Treatment of Dyskinesia in Parkinson's Disease Patients
Jan 24, 2020
Clene Nanomedicine Announces Formal Acceptance of CNM-Au8 for HEALEY ALS Platform Trial as Center Receives FDA Approval to Proceed
Jan 23, 2020
Risdiplam (RG7916) Pivotal FIREFISH Study Demonstrated Statistically Significant Improvement in Infants with Type 1 Spinal Muscular Atrophy
Jan 22, 2020
Biohaven's Verdiperstat Receives FDA May Proceed Letter To Initiate Trial In Amyotrophic Lateral Sclerosis Conducted By The Healey Center For ALS At Mass General